Trials

A Multicenter, Open-Label Phase 1b/2 Trial of Lenvatinib (E7080) Plus Pembrolizumab in Subjects With Selected Solid Tumors

Cancer type: Kidney

Phase: II

Principal Investigator: Haug Åse

Country: NO

Keywords: Norway, Bergen, Eisai Hope

Status: Open for inclusion

Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02501096?term=eisai+hope&rank=7